[Clinical aspect and therapy of BCG-lymphadenitis (author's transl)].
BCG-Lymphadenitis is a local complication of BCG-vaccination. The rate of complication depends on the kind of vaccine used, the dose and the used technique. In the last 9,5 years 32 infants with BCG-Lymphadenitis complicated with suppuration or perforation have been treated surgically. For 6 patients the treatment included a pre- and postoperative tuberculostatic therapy, for 11 patients included antibiotics. In 15 cases only surgical treatment was performed. In all 3 groups satisfactory results have been achieved, therefore tuberculostatic therapy seems not to be necessary and an antibiotic therapy ought to be reserved for cases with secondary miscellaneous infection. There is no doubt that it is possible to shorten the duration of this disease through early extirpation and to achieve a favourable cosmetic result too.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008199:Lymphadenitis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery / Q000628:therapy*; D014376:Tuberculosis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D001500:BCG Vaccine
Die BCG-Lymphadenitis und ihre Behandlung